Compare Phapros Tbk. (PEHA) vs Prodia Diagnostic Line Tbk (PRDL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Phapros Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Phapros Tbk. trades at Rp264 (market cap 221.76B), while Prodia Diagnostic Line Tbk trades at Rp270 (market cap 470.58B). The key difference: Prodia Diagnostic Line Tbk is far larger — about 2.1× Phapros Tbk.'s market cap. Which is the better fit depends on your goals.
| PEHA | PRDL | |
|---|---|---|
Market Cap | 221.76B | 470.58B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Phapros Tbk.
PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Read more on PEHA →About Prodia Diagnostic Line Tbk
PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →
